INTRODUCTION the major histocompatibility complex (MHC) and IBD have
The aetiology of the chronic inflammatory bowel diseases been observed in different groups of I·BD patients. in par (IBD), Crohn's disease (CD) and ulcerative colitis (UC) is still ticular the association between HLA-DR2 and UC [1] [2] [3] [4] [5] . unknown. However, there is overwhelming evidence th~lt Tumour necrosis factor alpha (TNFn) and lymphotoxin genetic factors playa role in the predisposition to suffer alpha (LT0: or TNF,3) playa central role in the initia tion and . This location has prompted much speculation about the role of TNF(l' and L Tn in the aetiology of MHC-associated diseases [6] . In support of this, MHC restricted differences in TNFu and LTn' inducibility have bccn demonstrated in several studies. Jacob et al. showed that HLA-DR2 positive individuals produce less TN ex than individuals that are HLA-DR3 positive [7] . Polymorphisms in the genes for TNFex (TNFA) and LTA appear to be responsible for differences in secretion, Messer et al. found that a NcoI restriction fragment length polymorphism (RFLP) in the first in tron of LT A influences LT ex secretion, and Pociot et al. found an association between this poly morphism and the production of TNF(' { [8] [9] [10] . An AspHI RFLP, also in the first intron of LTA, was described by
Ferencik et al. [II) . Wilson el al. described a polymorphism at position -308 in the promoter region of TN A that is strongly linked to the HLA-A 1,-B8,-DR3. ancestral haplotype, and suggested that variations at this position might be important in the regulation of TNFex production, although so far we know of no data that have been published to support this hypothesis [12, 13] . A second polymorphism, at position -238 in the promoter region of TNFA has been described by D'Alfonso & Momigliano Richiardi (14) .
In 200 Dutch individuals the aJleles of these four poly morphisms occur in only five combinations, TNF-haplo types: TNF-C, -E, -H, -I, and -P (Fig. I) [15) .
We recently observed large interindividual differences in the in vitro production of TNFex and LTex in ISO patients [16] . Therefore, to determine whether variations in the genes encoding these cytokines are responsible for differences in the intrinsic capacity of peripheral blood mononuclear cells (PBMC) to produce TNFex and LTex, we performed a prospective study in which we detemlined the production of these cytokines in vitro in relation to polymorphisms in the TNFA and LTA genes, as well as HLA-OR alleles in patients with ISO and healthy controls. 24-51 years), As TNF production may be influenced by female sex hormones [7] , only men or postmenopausal women were included. Diagnosis of CO or UC was based on the conventional clinical, radiological, endoscopic and pathological criteria, as described by Lennard-Jones [17] . UC disease activity was assessed using the Sutherland score [18) . The Crohn's disease activity index (COAl), according to Best and co-workers. was used for CD [19] . Of the CD paticnts, 13 were in remission at the time of study, with a CDA[ < 150, Two patients had active disease and were on prednisone therapy, [n the group of UC patients. 13 were in remission at the time of the study with a Sutherland score < 8, Two patients had a higher score and used prednisone, As our initial study design was to evaluate the relation between the LT A Ncol polymorphism and TNFa and LTn ~retion, selection of individuals was based on this gene polymorphism, Six individuals (3 CO, 2 UC, and I HC) were homozygous for allele I, 14 individuals (6 CD, 4 UC and 4 He) were heterozygous, and 22 (6 CD, 9 UC and 7 HC) were homozygous for allele 2, TNFA and LTA polymorphi.l'ms, Genomic DNA was extracted from anti-coagulated blood by a conventional proteinase K diges tion/phcnol-chloroform extraction method, Typing of the di-allelic poly-morphism at position -308 in the TNFA promoter (TNFA 308) was performed by PCR amplification (using a 5' primer 5' AGGCAATAGGTTTTGAGGGCCAT-3' and 5'-TCCTCCCTG CTC GATTCCG-3' as the 3' primer) and Nco[ digestion as described by Wilson el at. [12] , A ingle-strand conformation poly morphism method was optimized for the detection of di-allelic polymorphisms at both positions -308 and -238 in the TNFA gene, PCR fragments spanning sequences from position -396 to -69 were generated using a 5' primer 5'-TICCTGCATCCTGTCTGGAA-3' and a 3' primer 5'-CAGCGGAAAACTTCCTTGGT- 12.5% polyacrylamide PhastGels. Horizontal electrophoresis and silver staining were performed semi-automatically with the PhastSystem I \1 (Pharmacia LKB Biotechnology AB, Uppsala, Sweden). PCR amplification with primers located in the 5' untranslated region and third intron of the LTn gene (5' primer 5' -CCG TGCTTCGTGCTTTGGACTA-J' and 3' primer 5' -AGAGCT ,TGGGGACATGTCTG-3') resulted in 740 bp fragments that were either cut (allele LTA Ncol*l) or remained intact (allele LTA Ncol*2) following incubation with the restriction enzyme Neol [8] . For typing th LTA AspHI RFLP, as described by Ferencik el al., the 740 bp peR fragments were digested with the isoschi7.0mer
MATERIALS AND METHODS
HsiHKAI [I J]. This resulted in 415 and 315 bp fragments (allele LTA AspHI* I) or the undigested 740 bp fragment (allele LTA AspH1 *2). Fragments from individual digcsts were analysed by electrophoresis in 0.1 % cthidium bromidc stained 1.5% agarose gels.
DNA isolalion, PCR amplificalion, and dot-blolfing for HLA lyping. Amplification of the second exon of the HLA-DRBI gene was performcd by P R. Dot-blot analysis of amplificd DNA was carried out using the procedures [20] and biotin-.labelled sequence specific oligonucleotide probes (SSO) as described previously [2 I].
PBMC isolalion and cullure. PBMC were isolated immediately after collection of blood by density gradient centrifugation of heparinized blood on Ficoll-Hypaque (Lymphoprep) and cultured for 48 hat 3]0 under 5% CO 2 /humidified air at a concentration of 1.\06/ml. PBMC were cultured in RPMI 1640 with 25mM Hepes, with the following additives: L-glutamine, 2 mM, penicillin, 100 U/ ml, streptomycin, 100 fl-g/ml, and 10% pooled human scrum (the same batch was used for all experiments). Since TNFc\' is produced by activated monocytes and 1'-, B-and K cells and LTct by activated T-cells, we stimulated the PBM with T-cell activators. In order to achieve maximal stimulation we activated the l' cells with both 1 J.I.g/ml anti-D3 (monoclonal 15E8) and 1 fl-g/ml anti-CD28 (monoclonal 16A':!. kindly provided by Dr van Lier, CLB, Amster dam, the ctherlands [22) . nd r these circumstances, a maximal and reproducible secretion of TNFQ and TO' was achieved. The supernatants were har ested after 48 h in culture by gentle centrifu gation, aliquoled and stored al -80 C, and were not thawed until assay.
TNFa and LTO' measurelllenlS. TNFa and L (t were measured by commercially available ELlS systems, as described by the manu facturers. For l' FO' measurements, the TNFQ EASI was used (Medgenix Diagnostics A, F\eurus, Belgium), and for 1'(1'. lhe uanlikinc LTo ELlS was used R&D Systems, Minneapolis. USA). According to the manufacturers, the sensitivity of the TNF" ELISA is less than 15 pg/ml, and the intra-and interassuy coefficients of variancc were < 6% and < 10%, respectively. The sensitivity of the LTn ELISA is 7 pg/ml, with an intra-and interassay specificity of <4% and <8%, respectively.
Slatislies. The relation between genotypes and TNFO' or LTO' production was calculated by one-way and two-way analysis of variance for the comparison of groups, using the BMDP software package [23] . Subsequently, individuals were stratified for disease. P values after stratification for disease are designated as P s .
A P value < 0.05 was considered statistically significant. Where appropriate we tested for linear trend by specifying a linear contrast within the analysis of variance. In order to check normality of the distributions, we examined histograms of the data, both before and after logarithmic transformation. P values reported are from analy ses without the logarithmic transformation because, in general, this transformation dld not improve normality. When comparing two groups we used Wilcoxon's non-parametric two-sample test.
RESULTS

TNFO'. and LTO'. production in relation 10 dise(. e
The mean TNFO'. and LTO'. production upon stimulation with anti-CD3 and anti-CD28 is shown in Table 1 . In this selected study group, as defined in Materials and Methods, the mean TNFO'. and LTO'. production did not differ statistically signifi cantly between C patients, CD patients and HC (P > 0.05).
TNFO'. production in relation to lhe TNF polymorphisms
The TNFO'. production in relation to the TNF polymorphisms is shown in Tables 2a and b. As the infrequent haplotype TNF-H was not found in our study group, the relevance of the polymorphism at position -238 of the promoter region of TNFA could not be investigated.
When studying the polymorphism at position -308 in the promoter region of the FO'. gene, it was found that individuals homozygous for the TNFA -308*1 allele pro duced significantly less TNFrr upon stimulation than indi viduals homozygous for the TNFA -308*2 allele, whereas heterozygous individuals produced intermediate amounts (P = 0.014). As the number of individuals homozygous for the TNF -308*2 allele was small, it was not possible to stratify for disease. Therefore, carriers of the allele 2 were compared with non-carriers. After stratifying for disease, a statistically significant difference was found between carriers of allele 2 and individuals without this allele (P s = 0.032) (Fig. 2) No association was found between the LTA Ncol poly morphism and TNFa secretion, neither when individuals were compared (P = 0.521), nor after stratifying for disease (Ps = 0.756). No associations were found between the LTA AspHI polymorphism and TNFu secretion (P = 0.641, and P s = 0.666).
LTa production in rdation to the TNF polymorphisms
The production of LTa in relation to the TNF polymorph isms is shown in Tables 2a and b. As can be seen from these Table 3 . TNFa production in relation to TNF haplotypes tables, a statistically significant association was found between the TNFA -308 poly-morphism and LTa secretion (P = 0.012). However, when carriers of allele 2 were com pared with non-carriers, this difJ"erencc did not reach statis tical significance (Ps = 0 [69).
There was no statistically significant association between the LT A Ncol polymorphism (P = 0.098; P, = 0.271) or the LTA AspHI polymorphism (P = 0.656, and P s = 0.654) and the secretion of LTa.
TNFa production in relation to TNF haplotypes
The production of TNFa in relation to the TNF haplotypes is TNFa production in pg/ml ± SO. n = number of individuals carrying the TNF haplotype. shown in Table 3 . Individuals carrying the TNF-C haplotype were low producers of TNFo: (P = 0.022 and P, = 0.045 as compared to individuals without this haplotype). Individuals carrying the TNF-E haplotype (i.e. carriers of allele 2 of the TNFo: -308 polymorphism) are high producers of TNFo:
(P = 0.014 and P, = 0.032). The TNF-C haplotype and the TNF-E haplotype differ only at position -308 in the promoter region of the TNFo: gene. Individuals carrying the TNF-C haplotype differed statistically significant in TNFo: secretion from those carrying the TNF-E haplotype (mean 17473 pgj ml versus 27050 pgjml; P = 0.007 and P s = 0.024). Indi viduals carrying both the TNF-C and TNF-E haplotypes were excluded from this analysis. With regard to the TNF-I haplotype, there was a trend towards lower TNFo: secretion when carriers were compared with non-carriers of this haplotype (P = 0.062). After strati fication for disease, this difference reached statistical signifi cance (P s = 0.024). No association was found between the TNF-P haplotype and secretion of TNFo: (P = 0.746 and P s = 0.829).
LTo: production in relation to TNF haplotypes
The production of LTo: in relation to the genotypes is shown in Table 4 . Individuals carrying the TNF-I haplotype showed a statistically very significant lower production of LTo: as compared to individuals who lack this haplotype (P = 0.006; P s = 0.006).
TNFo: and LTo. secretion in relation to HLA-class II alleles
In a previous study of IBD patients we showed that the TNF E haplotype is in linkage disequilibrium with the HLA-DR3 allele, whereas the TNF-I haplotype was found to be associ ated with the HLA-DRI allele (24] . Therefore, we also studied TNFo. and LT,t secretion in relation to the HLA DR alleles in 30 IBD patients and II HC Carriage of the HLA-DR alleles and TNF haplotypes is shown in Table 5 . We observed a strong association between the TNF-E haplo type and the HLA-DR3 allele. In this study group all HLA DR3 positive individuals also carried the TNF-E haplotype, whereas 12 out of 17 (71 %) haplotype TNF-E positive individuals were also HLA-DR3 positive. TNFo. secretion in relation to HLA-DR3 and TNF-E is shown in Table 6 . As can be seen from the table, no differences were found between HLA-DR3 +, TNF-E+ individuals and HLA-DRr, TNF E + individuals, but secretion was significantly higher than in HLA-DRr, TNF-E individuals (P = 0.028 by testing for linear trend).
The frequency of the HLA-DRI allele was increased in individuals carrying the TNF-I haplotype as, of the 13 TNF 1+ individuals, six were DRI + (Table 5) . LTo: secretion in * Significantly increased as compared to HLA-DRr /TNF-E-(P = 0.028). ** Significantly decreased as compared to HLA-DR-['-rrNF-r-(P = 0.006).
relation to the HLA-DRI allele and the TNF-I haplotype is shown in Table 6 . No statistically significant differences between HLA-DRI +, TNF-I-individuals, HLA-DRI +, TNF-I-individuals, HLA-DRr-, TNF-I I individuals, and HLA-DRI +, TNF-I-individuals were found (P = 0.093). However, the difference between HLA-DRr-, TNF-I-indi viduals and HLA-DRI +, TNF-I+ individuals was highly significant (P = 0.006).
DISCUSSION
Recent observations have shown that the polymorphism at position -308 in the promoter region of TNFA is involved in the susceptibility for at least two diseases: cerebral malaria and mucocutaneous Leishmaniasis [25, 26] . Individuals carry ing the allele 2 have a highly increased risk of developing these severe diseases. Wilson el at. already suggested that this position may be of importance for the regulation of TNFo: secretion [13, 27] , but, to our knowledge, no data exist to support this hypothesis. There is one abstract reporting that the TNF2 allele in gene assays directs higher levels of transcription [28] , and another finding no differences in a similar assay [29] . In this study we have evaluated the relationship between polymorphis.ms in the genes encoding TNFa and LTa and the intrinsic capacity of PBMC to produce these cytokines when T-cell stimulators are used. Although our study population was small, we present, for the first time, four lines of evidence to support the idea that this position is associated with differences in TNFa secretion. (I) Individuals homozygous for the TNFA NcoI*1 allele produced significantly less TNFa than individuals homo zygous for the TN FA NcoI*2 allele, whereas heterozygous individuals produced intermediate levels of TN Fa. However, the number of homozygous TNFA NcoI*2 patients was too low to allow stratification for disease. Therefore, we com pared carriers of allele 2 with non-carriers of allele 2, and showed that the carriers of allele 2 are high producers of TNFa, (2) When TNFa secretion was studied in relation to the TNF hap[otypes, strong associations were found, High TNFa production was found in individuals carrying the TNF-E haplotype, whereas low TNFa production was found in individuals with the TNF-C haplotype. These haplotypes differ only at position -308 in the promoter region of TNFA.
(3) In a previous study on the immunogenetics of TNFa, Jacob el at. showed that HLA-DR2 positive individuals produce less TNFa than HLA-DR3 or DR4 positive indi viduals [7] . Therefore, it might theoretically be that the HLA class II genes influence the regulation ofTNF secretion. In the present study, however, we found no differences between DR3-, TNF-E+ individuals and HLA-DR3+, TNF-E+ individuals, but a significant lower secretion in HLA-DRr, TNF-E-individuals, suggesting that the TNF-E haplotype is stronger associated with the increased TNFa secretion than the HLA-DR3 allele.
(4) In support of our intcrpretation we can add another observation. Abraham el at. studied spontaneous TNFn secretion in B-Iymphoblastoid cell lines and found large differences in secretion of TNFo: between cell lines [29] . We have typed two of the high TNFa producing cell lines (numbers 9022 (COX) and 9023 (V AVY), according to the 10th International Histocompatibility Workshop) for the TNF haplotypes, and found that both are homozygous for the TNF-E haplotype [30] .
Since TNFo· is mainly produced by macrophages, LPS and PMA are frequently used stimulants to study the relationship between gene polymorphisms and production [8, 10] . Messer el at. reported a correlation between the LT A Ncol poly morphism and LTa production [8] . In concordance with Pociot el at. we found no statistically significant correlation between this polymorphism and LTa production [10] . The differences observed between these studies may possibly be due to different study designs. As T cells are thought to be the essential cells in the pathogenesis of autoimmune diseases [31] , we activated the PBMC with T-cell specific activators. Interestingly, TNFa secretion after 24 h LPS stimulation was also found to be significantly higher in TNFA -308*2,2 individuals as compared to those homozygous for allele (resul ts not shown).
We found no significant associations between any of the polymorphisms studied and LTa production (Tables 2a & b) . However, when we studied LTa production in relation to the TNF haplotypes, we found a very strong association between (I·; 1996 Blackwell Science Ltd, Scandinavian Journal oj Immunology, 43, 456-463 I LTex production and the TNF-l haplotype. Individuals carry ing this haplotype produce significantly less LTo< and TNFo< upon stimulation than individuals who lack this haplotype, irrespective of disease status. The HLA-DR I associated TNF-I haplotype thus seems to define a low-secretor pheno type for these cytokines. As the TNF-I haplotype differs in at least two positions from the other TNF haplotypes, our finding suggests that there must be an additional factor(s) in the TNF-I haplotype that down-regulates the production of these cytokines. Furthermore, these observations demon strate that the study of haplotypes, rather than individual gene polymorphisms, may occasionally provide additional information, and should be taken into account when studying the immunogenetics of cytokines.
What is the importance of the present findings to the predisposition to lBD? TNFo< facilitates inflammatory cell infiltration by promoting adhesion of neutrophils and lymphocytes to endothelial cells and up-regulates the expres sion of HLA molecules in human colonic cell lines and small intestinal epithelial cells [32, 33] , all being important features of inflammatory bowel disease. In this respect, it is interesting that there is recent evidence that a monoclonal anti-TNFn antibody induces active CD into remission [34] . In a previous study, we investigated the distribution of the four polymorph isms and TNF haplotypes in a large group of IBD patients and He. We found a weak, but statistically significant, association between the TNFA NcoI polymorphism and Ue. The infrequent allele 2 was found to be decreased in UC patients as compared to HC [24] . The strength of the association indicates, however, that these genes are not markers for disease predisposition. They may, however, be markers of subsets of patients with UC and CD. From the clinical point of view, UC and CD are heterogeneous diseases [35, 36] . Individual CD or UC patients can differ extremely in their course of the disease, prognosis and response to medical. treatment; some patients respond well to standard treatment while others are therapy resistant.' In some patients the disease is restricted to a small part of the intestinal tract while in others extended intestinal inflammation can be found. In a subgroup of patients, extra-intestinal manifesta tions, such as arthritis. are found. These clinical. observations havc led to investigations to determine whether IBD may actually represent a set of diseases that display a simitar clinical picture, but have a wide variety of aetiologies. Recent data from animal models of intestinal inflammation support this hypothesis, showing that very different muta tions can induce diseases with remarkably simitar phenotypes [37] . As has been suggested for othcr diseases, subgroups of patients may therefore have a heterogeneous genetic back ground [38, 39] . For example, in paticnts with systemic lupus erythematosis (SLE), there is an increased incidence of nephritis in HLA-DR2+, DQl + patients, but not in DR3 + individuals [40] .
In conclusion, the results of the present study support the concept that a different immunogenetic background may determine the height of the immune response. High and low secretor phenotypes are present in lBD patients, and may determine the number and severity of relapses in an indi vidual patient. These clinical features will be studied in a prospective manner in relation to the genetic markers. Our study suggests that studying cytokine genes may help to understand the biological basis of disease heterogeneity in IBD, and may be helpful to design a more rational thera peutic approach for patients with these diseases.
